| Market Cap | ₹3,399Cr |
| ROE | 9.93% |
| P/E Ratio(TTM) | 22.55 |
| EPS(TTM) | 13.47 |
| P/B Ratio | 2.29 |
| Dividend Yield | 1.71% |
| Industry P/E | 33.18 |
| Book Value | 132.64 |
| Debt to Equity | 0.02 |
| Face Value | 2 |
| Parent Organisation | Advanced Enzyme Technologies Limited |
| Managing Director | Shri. Chandrakant Rathi |
| NSE Symbol | ADVENZYMES |
| FUND NAME | AUM(%) |
|---|---|
| Bank of India Small Cap Fund Direct Growth | 0.36% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 68.80 | ||
| Anthem Biosciences | NA (0.00%) | 72.79 | ||
| Onesource Specialty Pharma | NA (0.00%) | 472.59 | ||
| Panacea Biotec | NA (0.00%) | -278.87 |